Oireachtas Joint and Select Committees

Wednesday, 12 July 2017

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion

9:00 am

Professor Michael Barry:

It is important to say that when we do the assessments we are tick tacking over with the companies that are, in general, very co-operative in this. Where we do disagree then at least we know where we disagree. That is the value of this system. It is very transparent and we know exactly what the sticking points are.